Humens

Humens is a leading global producer of high-purity mineral specialties, specifically sodium bicarbonate and soda ash, serving the pharmaceutical, hemodialysis, and personal care industries. Established as an independent entity in 2021 following a carve-out from the Seqens Group (formerly Novacap), the company operates with a manufacturing heritage dating back to 1855. Humens provides essential pharmaceutical-grade ingredients that are critical for life-sustaining treatments such as hemodialysis and various pharmaceutical formulations. The company operates two major production sites: the historic La Madeleine plant in France and a state-of-the-art facility in Singapore. Currently backed by the investment firm Eurazeo, Humens focuses on high-quality, sustainable production to meet the rigorous standards of the global healthcare market.